I was corrected for suggesting RRL's last year exploration spend of $18m was all on Mcphillamys. Fair enough.
Slide 5 note 2 of this prez forecasts FY22 Mcphillamys exploration spend of $29m.
Holders chafe at approval delays which stand between them and the immediate capitalisation of Mcphillamys full value.
RRL continues to advance the project and look confident of ultimate success.
Ash
- Forums
- ASX - By Stock
- RRL
- Ann: 2022 Bell Potter Unearthed Conference Presentation
Ann: 2022 Bell Potter Unearthed Conference Presentation, page-7
-
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RRL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.45 |
Change
-0.015(0.61%) |
Mkt cap ! $1.847B |
Open | High | Low | Value | Volume |
$2.44 | $2.46 | $2.42 | $5.698M | 2.335M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
36 | 64330 | $2.44 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.45 | 86092 | 53 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 35756 | 2.440 |
27 | 169815 | 2.430 |
18 | 123850 | 2.420 |
10 | 68233 | 2.410 |
13 | 245154 | 2.400 |
Price($) | Vol. | No. |
---|---|---|
2.450 | 155805 | 41 |
2.460 | 226926 | 26 |
2.470 | 64714 | 8 |
2.480 | 34851 | 6 |
2.490 | 222372 | 4 |
Last trade - 15.07pm 13/11/2024 (20 minute delay) ? |
Featured News
RRL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online